Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 162
Selected: 0
NCT IDTitle
NCT06827431The Research of Ammoxetine Hydrochloride Enteric-coated Tablets in Subjects With Depression
NCT04689100Efficacy and Safety of JMT101 in Patients With Advanced Solid Tumor
NCT07163364A Study to Evaluate the Effects and Safety of Hydroxocobalamin in Participants With Combined Methylmalonic Academia (cblC Type)
NCT04886765A Study to Evaluate the Safety and Efficacy of ALMB-0168 in Patients With Osteosarcoma
NCT04900766A Study of Mitoxantrone Hydrochloride Liposome Injection in Subjects With Advanced Bone and Soft Tissue Sarcoma
NCT03553914PLM60 for Peripheral T Cell Lymphoma (PTCL)
NCT04902027A Study of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Recurrent/Metastatic Head and Neck Cancers
NCT04331743A Study to Evaluate the Safety and Efficacy of PLM60 in Advanced HCC
NCT05055791A Study to Evaluate the Safety and Tolerance of SYHX1903 in Patients With Relapsed/Refractory Hematologic Malignancies
NCT04309968Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Anti-tumor Activity of SYHA1801 Monotherapy in Patients With Advanced Solid Tumors
NCT03777579A Study of First-line JS001 and Nab-paclitaxel Versus Palcelbo and Nab-Paclitaxel in Participants With Advanced Recurrent or Metastatic TNBC
NCT04015024A Clinical Study of SKLB1028 Capsule in the Treatment of Recurrence/Refractory AML Patients
NCT05070195A Study to Investigate the Drug-drug Interactions (DDIs) Between SKLB1028 and Midazolam in Healthy Subjects
NCT04161430A Study to Evaluate the Efficacy and Safety of DBPR108 100 mg in Type 2 Diabetes Mellitus Patients
NCT01342042The Safety,Preliminary Pharmacodynamics and Pharmacokinetics Study of rExenatide-4 in Chinese Type 2 Diabetes Mellitus
NCT05132777Efficacy and Safety of JMT101 Combined With Osimertinib in Patients With Non-Small Cell Lung Cancer
NCT05715840Efficacy and Safety Study of First-line Treatment With SG001 Plus Chemotherapy ± Bevacizumab Versus Placebo Plus Chemotherapy ±Bevacizumab for Recurrent, or Metastatic Cervical Cancer With PD-L1 Positive (CPS≥1)
NCT06929325Sirolimus for Injection (Albumin-bound) Combined With Fulvestrant for HR+/HER2- Advanced/Metastatic Breast Cancer Patients Previously Treated With CDK4/6 Inhibitors
NCT05478785A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Efficacy of Cisplatin Micelle Injection (HA132) in Patients With Advanced Malignant Solid Tumors
NCT04198480A Clinical Trial to Assess the Efficacy and Safety of JMT103 in Patients With Refractory HCM
NCT04124484DBPR108 Tablets in Type 2 Diabetes Mellitus Patients
NCT04859452A Study to Evaluate the DDI of DBPR108 With Metformin,Glibenclamide,Valsartan, or Simvastatin in Healthy Subjects
NCT06313086DP303c Versus Trastuzumab Emtansine in in Patients With HER2-positive Advanced Breast Cancer
NCT03722914A Study on the Efficacy and Safety of Benzonatate Soft Capsules for Improving Adult Cough Symptoms
NCT04931823Dose Escalation and Dose Expansion Study of CPO-100 in Patients With Advanced Solid Tumors
NCT04718376A Study of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Relapsed Ovarian Cancer
NCT02597153Phase II Clinical Study of PLM60 for the Treatment of Cutaneous T Cell Lymphomas
NCT05445154SKLB1028, Daunorubicin, and Cytarabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)
NCT06492941A Study of Docetaxel for Injection (Albumin Bound) in Patients With Advanced Pancreatic Cancer
NCT03577509Single Dose Escalations Study of Amphotericin B Colloidal Dispersion In Healthy Subjects in China
NCT03239119The Effectivity and Safety Study of rExenatide-4 in Chinese Type 2 Diabetes Mellitus
NCT05097248Camrelizumab in Combination With PLD and Losartan in Patients With TNBC Who Have Received ≦ 1 Line of Chemotherapy
NCT05863325A Study to Compare the Efficacy and Safety of HB1801 to Taxotere in Advanced Non-Small Cell Lung Cancer (NSCLC)
NCT04453618A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Food Effect of SYHA1402 in Healthy Subjects
NCT02596373A Study of Mitoxantrone Hydrochloride Liposome Injection in Advanced Recurrent or Metastatic Breast Cancer
NCT05072535A Study to Evaluate Relative Bioavailability and Food-Effect of HA121-28 Tablet B in Healthy Subjects
NCT04448379Efficacy and Safety of JMT101 Combined With Afatinib (or Osimertinib) in Patients With Non-Small Cell Lung Cancer
NCT06941142A Study of Sirolimus (Albumin-Bound) in Combination With Palbociclib and Fulvestrant for the Treatment of Advanced Breast Cancer
NCT05009966Study of SYSA1801 in the Treatment of Claudin( CLDN) 18.2 Positive Advanced Malignant Solid Tumor
NCT06511739A Study to Evaluate the Efficacy and Safety of SYHX1901 Tablet in Non-segmental Vitiligo Patients
NCT04404543A Study of SYHA1807 in Subjects With Extensive-Stage Small Cell Lung Cancer
NCT04718402A Study of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Advanced Gastric Carcinoma
NCT04719065A Study of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Advanced Solid Tumor
NCT05774340A Study of CM326 in Subjects With Moderate to Severe Asthma
NCT05810103A Study of DP303c in Patients With HER2-positive Advanced Solid Tumors
NCT05072522A Study of SKLB1028 in Patients With Advanced Solid Tumor
NCT02597387Clinical Trial of Mitoxantrone HCL Liposome Injection in Patients With Relapsed DLBCL and PT/NKCLs
NCT05901935DP303c in Patients With HER2-positive Advanced Breast Cancer
NCT04218734A Study of DBPR108 and Metformin Hydrochloride Combination Therapy in Patients With T2DM
NCT05100303A Study to Evaluate the Tolerance and Efficacy of Mitoxantrone Hydrochloride Liposome Injection Combined With Cytarabine in Patients With Acute Myeloid Leukemia (AML)